Timor treatment via the intracancer injection of a biocompatible gel with radioactive particles
Seventeen has raised €4.2M across 1 funding round from 2 investors, most recently a Series A round in Sep 2016. Based in Italy; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-09-01 | Series A | €4.2M |
| Innogest Capital,Panakes Partners |
| View deal → |
